Position in IONS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$8,672,660
-$43,535,614 QoQ
Shares Held
109,379
-84.3% QoQ
Ownership
0.066%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#122
of 513 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Derivatives in IONS
reported options exposure · as of Dec 31, 2025CallValue
$276,885
CallShares
3,500
PutValue
$245,241
PutShares
3,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. IONS ranks #35 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
198,567 | $123,814,467 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
1,191,732 | $88,760,199 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
233,999 | $70,440,718 | |
| 4 | INSM |
INSMED Inc
|
616,464 | $65,727,391 | |
| 5 | ARGX |
Argenx SE
|
58,400 | $54,181,768 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
422,921 | $46,956,918 | |
| 7 | APGE |
Apogee Therapeutics, Inc.
|
290,713 | $38,586,336 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
154,605 | $37,842,665 |
All Filings in IONS
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,672,660 | 109,379 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $52,208,274 | 695,276 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $276,885 | 3,500 | Call | Defined | 2026-02-13 | |
| 2025-12-31 | $34,514,031 | 436,279 | Shares | Defined | 2026-02-13 | |
| 2025-12-31 | $245,241 | 3,100 | Put | Defined | 2026-02-13 | |
| 2025-09-30 | $1,439,240 | 22,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $3,670,062 | 56,100 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $25,107,672 | 383,792 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $5,309,946 | 134,395 | Shares | Defined | 2025-08-27 | |
| 2025-03-31 | $9,213,103 | 305,373 | Shares | Defined | 2025-08-27 | |
| 2024-12-31 | $5,819,721 | 166,468 | Shares | Defined | 2025-02-14 | |
| 2024-12-31 | $209,760 | 6,000 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $5,101,280 | 127,341 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $20,818,745 | 436,818 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $32,303,249 | 745,173 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $2,995,130 | 59,204 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $6,328,627 | 139,520 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $2,782,203 | 67,809 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,052,916 | 113,400 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,836,634 | 181,007 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $4,071,548 | 92,054 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $4,810,378 | 129,940 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $699,833 | 18,894 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,866,576 | 61,340 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $5,697,272 | 169,865 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,904,548 | 47,745 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $880,631 | 19,587 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $5,851,324 | 103,490 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,254,785 | 68,594 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $640,010 | 10,855 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $7,004,248 | 148,144 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||